cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.25549/gar-c81-35955
title: Caspar Whitney, letter, 1920-04-13, to Hamlin Garland

description: Caspar Whitney, Hotel Gramatan, [85 Pondfield Road], Lawrence Park, Bronxville, New York, USA, letter, 1920 April 13, to Hamlin Garland. "Your note of endorsement is fine!" -- first line.
DOI: 10.25549/gar-c81-26488
title: John Sanburn Phillips, letter, 1897-03-27, to Hamlin Garland

description: John Sanburn Phillips (The S.S. McClure Company), 141-155 East 25th Street, New York, New York, USA, letter, 1897 March 27, to Hamlin Garland, 1342 New York Avenue, Washington, DC, USA. "We will need the June manuscript in about ten days or two weeks." -- first line. With envelope.
DOI: 10.6075/j08s4n5g
title: GECS0JMV Geosecs Expedition Leg J - Cruise Report. In Data from Scripps Research Expeditions 1953-2005

description: Geochemical ocean sections (geosecs). chemical analysis of large sea water samples.
DOI: 10.26179/qh02-pr41
title: 40Ar/39Ar Geochronology of Legacy Samples Heard Island
DOI: 10.6084/m9.figshare.23272853
title: Association between triglyceride-glucose index and acute kidney injury in patients with acute myocardial infarction based on Medical Information Mart for Intensive Care database : A cross-sectional study.

description: <strong>Methods: </strong>Participants were enrolled from Medical Information Mart for Intensive Care IV (MIMICIV) and grouping of subjects based on the quartile interval of the TyG index. With the presence of AKI as the main outcome, a logistic regression model was constructed. The correlation of the TyG index with the results obtained was examined by using a restricted cubic spline (RCS) model. <strong>Results:</strong> Among the 1,101 AMI participants, 64.7% were male patients and the overall incidence rate of AKI was 37.1%. The results of multivariate Logistic regression analysis (LRA) revealed independent correlation of the TyG index with increased AKI risk <strong>[odds ratio (OR) = 2.23; confidence interval (CI) = 1.59 to 3.17; P &lt; 0.001]</strong>. Q4 (9.5-12.208) in the TyG index quartile was independently correlated with increased AKI risk<strong> (OR = 2.99, 95% CI = 1.64 to 5.46, P &lt; 0.001)</strong>. The RCS model showed that the AKI risk increased linearly as the TyG index increased (P=0.313).
DOI: 10.6084/m9.figshare.23272853.v1
title: Association between triglyceride-glucose index and acute kidney injury in patients with acute myocardial infarction based on Medical Information Mart for Intensive Care database : A cross-sectional study.

description: <strong>Methods: </strong>Participants were enrolled from Medical Information Mart for Intensive Care IV (MIMICIV) and grouping of subjects based on the quartile interval of the TyG index. With the presence of AKI as the main outcome, a logistic regression model was constructed. The correlation of the TyG index with the results obtained was examined by using a restricted cubic spline (RCS) model. <strong>Results:</strong> Among the 1,101 AMI participants, 64.7% were male patients and the overall incidence rate of AKI was 37.1%. The results of multivariate Logistic regression analysis (LRA) revealed independent correlation of the TyG index with increased AKI risk <strong>[odds ratio (OR) = 2.23; confidence interval (CI) = 1.59 to 3.17; P &lt; 0.001]</strong>. Q4 (9.5-12.208) in the TyG index quartile was independently correlated with increased AKI risk<strong> (OR = 2.99, 95% CI = 1.64 to 5.46, P &lt; 0.001)</strong>. The RCS model showed that the AKI risk increased linearly as the TyG index increased (P=0.313).
DOI: 10.5517/ccdc.csd.cc2f8g5c
title: CCDC 2242452: Experimental Crystal Structure Determination

description: Related Article: Benjamin Rudin, Lukas Eberle, Joachim Ballmann|2023|Organometallics|42|933|doi:10.1021/acs.organomet.3c00107
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2f8g6d
title: CCDC 2242453: Experimental Crystal Structure Determination

description: Related Article: Benjamin Rudin, Lukas Eberle, Joachim Ballmann|2023|Organometallics|42|933|doi:10.1021/acs.organomet.3c00107
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2f8g9h
title: CCDC 2242456: Experimental Crystal Structure Determination

description: Related Article: Benjamin Rudin, Lukas Eberle, Joachim Ballmann|2023|Organometallics|42|933|doi:10.1021/acs.organomet.3c00107
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2f8gbj
title: CCDC 2242457: Experimental Crystal Structure Determination

description: Related Article: Benjamin Rudin, Lukas Eberle, Joachim Ballmann|2023|Organometallics|42|933|doi:10.1021/acs.organomet.3c00107
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2f8gck
title: CCDC 2242458: Experimental Crystal Structure Determination

description: Related Article: Benjamin Rudin, Lukas Eberle, Joachim Ballmann|2023|Organometallics|42|933|doi:10.1021/acs.organomet.3c00107
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2f8gdl
title: CCDC 2242459: Experimental Crystal Structure Determination

description: Related Article: Benjamin Rudin, Lukas Eberle, Joachim Ballmann|2023|Organometallics|42|933|doi:10.1021/acs.organomet.3c00107
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2f8gfm
title: CCDC 2242460: Experimental Crystal Structure Determination

description: Related Article: Benjamin Rudin, Lukas Eberle, Joachim Ballmann|2023|Organometallics|42|933|doi:10.1021/acs.organomet.3c00107
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2f8ggn
title: CCDC 2242461: Experimental Crystal Structure Determination

description: Related Article: Benjamin Rudin, Lukas Eberle, Joachim Ballmann|2023|Organometallics|42|933|doi:10.1021/acs.organomet.3c00107
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2f8ghp
title: CCDC 2242462: Experimental Crystal Structure Determination

description: Related Article: Benjamin Rudin, Lukas Eberle, Joachim Ballmann|2023|Organometallics|42|933|doi:10.1021/acs.organomet.3c00107
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.25934/pr00007473.0
title: Available IPD datapackage for study 'A Phase I, Open-label, Dose-finding Study of GSK2636771 Administered in Combination With Enzalutamide (Xtandi^TM ) in Male Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)'

description: This Phase I, open-label, dose-finding, multicenter study is designed to determine the recommended Phase II dose (RP2D) for the combination of an orally administered Phosphatidylinositol-4,5-bisphosphate 3-kinase beta (PI3K-beta) inhibitor (GSK2636771) with enzalutamide. Subjects with phosphatase and tensin homolog (PTEN)-deficient metastatic castration-resistant prostate cancer (mCRPC) who are receiving a stable dose of enzalutamide with a recently demonstrated progression (either by RECIST [Response Evaluation Criteria In Solid Tumors] version 1.1, prostate-specific antigen [PSA] progression, and/or progression in bone) per the Prostate Cancer Working Group 2 (PCWG2) criteria will be enrolled. Eligible subjects will be enrolled in the Dose-Escalation Phase to determine the maximum tolerated dose (MTD) of the combination therapy using a modified 3+3 dose escalation procedure. The safety, pharmacokinetics (PK) and clinical efficacy will also be assessed to guide the selection of the RP2D. The starting dose will be GSK2636771 300 mg once daily in combination with the recommended dose (160 milligram [mg] once daily) of oral enzalutamide. Once the RP2D has been established, additional subjects will be enrolled in the Dose Expansion Phase to further evaluate the safety, PK and preliminary clinical activity. Safety assessments will be performed throughout the study including physical examinations, vital signs, clinical laboratory tests, 12 lead electrocardiograms and monitoring of adverse events. Blood samples will be collected for pharmacokinetic analysis. Subjects will continue treatment until an unacceptable toxicity, disease progression, withdrawal of consent or death occurs. A post-treatment follow-up visit will be performed within 30 days of the last dose of study treatment. Xtandi is a registered trademark of Astellas Pharma Inc
DOI: 10.15151/esrf-es-1182803822
title: Feasibility tests of PCT, DCT and s-3DXRD in Ni superalloys and martensitic steels

description: Samples will be tested for the feasibility of a combination of both DCT and s-3DXRD techniques in martensitic steels. Ni superalloys will be characterized by PCT for crack detection and DCT as feasibility tests.
DOI: 10.6084/m9.figshare.23274299
title: GBD of IHD(1990 to 2019)

description: Accurate and comprehensive data on the incidence, mortality, and burden of ischemic heart disease (IHD), as well as the associated risk factors, are essential for informed decision-making in healthcare policy. This study aimed to estimate IHD incidence, deaths, and disability-adjusted life years (DALYs) stratified by country, gender, age group, and sociodemographic status from 1990 to 2019. Through statistical analysis of the global population and IHD data from the GBD database from 1990 to 2019, we analyzed the region, sex, age characteristics, and temporal development of IHD. At the same time, we also included the relevant influencing factors of the sociodemographic index (SDI) and analyzed the incidence of IHD in regions with different SDI levels. Furthermore, we examined the primary risk factors for IHD during the same period and employed statistical models to predict the global IHD incidence through 2044.
DOI: 10.34740/kaggle/dsv/5822795
title: Elon Musk Tweets
DOI: 10.6084/m9.figshare.23274389
title: Supplementary Material for: Alterations of UHRF family expression and UHRF1/ICBP90 inhibits PTEN expression in endometrial cancer

description: Introduction: The altered protein expression of inverted CCAAT box-binding protein of 90 kDa/ubiquitin-like with PHD and RING finger domains 1 (ICBP90/UHRF1) and Np95-like ring finger protein (NIRF)/UHRF2, which belong to the ubiquitin-like with PHD and RING finger domains (UHRF) family, is linked to tumor malignancy and the progression of various cancers. To determine the role of NIRF and ICBP90 in endometrial tumorigenesis, we evaluated ICBP90 and NIRF expression levels in endometrial cancers. Also molecular alterations of PTEN expression is the important event for endometrial carcinogenesis, therefore we investigated the involvement between ICBP90 and PTEN expression. Methods: We used Western blot for NIRF, ICBP90, and PTEN expression, mutation analysis of NIRF gene, and immunohistochemical staining for the expression of NIRF and ICBP90. For immunohistochemical staining, we examined atypical endometrial hyperplasia, endometrial cancers, and non-cancerous samples. Results: Our data showed that the reduced expression of NIRF and overexpression of ICBP90 occurred in atypical endometrial hyperplasia and endometrial cancer compared to the normal endometrium. The decrease in NIRF expression was significantly correlated with histological grade. Expression of ICBP90 was high, especially in the peripheral margin of a cancer nest. Western blot analysis of endometrial cancer cell lines referred an opposite correlation between ICBP90 and phosphatase and tensin homolog (PTEN) expression. Conclusion: Our findings suggested that continually overexpressed ICBP90 may contribute to the inhibition of PTEN expression, which is a frequent and important event in endometrial carcinogenesis. We propose that the reduced NIRF expression and ICBP90 overexpression is an early event in endometrial carcinogenesis; thus ICBP90 may be useful as a therapeutic target in this disease.
DOI: 10.5281/zenodo.7852407
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7858787
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7863905
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7866789
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7868206
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7875815
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7883449
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7890429
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7891746
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7892433
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7892944
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7908659
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7919283
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7919584
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7919685
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7930289
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7930356
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7937164
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.
DOI: 10.5281/zenodo.7937396
title: TSlam-mapping-data

description: This repository contains all the data for the mapping phase of TSlam. This data is necessary for each specimen inference TSlam. Each szip folder contains: - the optimized .map file - the .ply model reconstructed from the map - the -mp4 videos of the raw feed and with GUI - the .yml file corresponding to the map with the list and pose of tags detected
description: FIRST upload. The dataset will be built progressively.